Company Overview
About DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a secure, scalable, and regulatory-compliant cloud environment where pharmaceutical companies, genomics labs, biobanks, health systems, and research institutions can store, analyze, and share multimodal biomedical data — including genomic sequences, clinical records, imaging, and real-world evidence. The platform is purpose-built for the data types, compliance requirements, and computational workloads unique to biomedical research and precision medicine development.
Business Model & Competitive Advantage
DNAnexus secured $200M in Series I financing led by Blackstone Growth in March 2022, with participation from Northpond Ventures, GV (Google Ventures), Perceptive Advisors, Innovatus Capital Partners, and Foresite Capital. Total funding exceeds $300M. The platform stores over 65 petabytes of data — growing at 70% per year since 2015 — and serves more than 12,000 users across 48 countries. Customer penetration in the pharma industry is exceptional: seven of the top 10 global pharmaceutical companies and eight of the top 10 diagnostics companies rely on DNAnexus for their precision medicine workflows.
Competitive Landscape 2025–2026
In 2025, DNAnexus CEO Thomas Laur was named among the Top Healthcare Technology CEOs of the Year, and the company received recognition from Frost & Sullivan for leadership in precision health informatics. DNAnexus competes with AWS HealthLake, Microsoft Azure Genomics, and Terra (Verily/Broad Institute) for the cloud genomics market. Its differentiators include deep workflow automation capabilities via the WDL/CWL standards, robust access controls for population-scale biobanks, and its long track record serving the most data-sensitive research environments in life sciences.
Key Differentiators
Market Leader
DNAnexus is recognized as a market leader in the Life Sciences & BioTech sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Saama Analytics
Saama Analytics is the leading AI-driven clinical analytics and data management platform for the life sciences industry, positioning itself as the "#1 in AI Clinical Analytics" based on customer adopt
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Compare DNAnexus with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from DNAnexus? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim DNAnexus Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention DNAnexus vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →